Back to Results

Orion Oyj ADR (ORINY)

Featured in Bullish Trend Stocks

Orion Oyj ADR is a depositary receipt tied to Orion Oyj’s common stock and listed on OTC Markets. Orion Oyj is a Finnish pharmaceutical company engaged in the development, manufacturing, and marketing of human and veterinary medicines, as well as active pharmaceutical ingredients. Its product range includes treatments used in oncology, Parkinson’s disease, pain management, menopausal symptoms, heart failure, asthma, chronic obstructive pulmonary disease, rheumatoid arthritis, and selected psychiatric conditions. The company also supplies veterinary medicines, contract manufacturing services, self-care products, and APIs for both generic and proprietary compounds. In addition, Orion sells products online and markets certain third-party medicines. Founded in 1917 and headquartered in Espoo, Finland, the company also maintains licensing arrangements with Tenax Therapeutics and Bayer related to specific development and commercialization programs.


Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ

Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Overall Financial Health Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
OTC-ORIN.Y
$48.17
2.1% Upside
Fair
Not available
Not available
Great
1.1%
February 17, 2027
19.9x
9.2x
5.7x
13.546 B
13.325 B
1.1%
87.4%
13.6
41.3%
67.0%
Valuation • Fair Value

Orion Oyj ADR (OTC-ORIN.Y) Fair Value by Valuation Model

Review the available estimates for Orion Oyj ADR (OTC-ORIN.Y), including DCF Fair Value, Ben Graham Formula Value, DDM Fair Value, EPV Fair Value, Comps Fair Value.

Primary Valuation Read

Fair Value

$48.17

Estimated upside of 2.1% versus the current market price.

Fair Value Confidence

High

Confidence level for the primary fair value estimate.

DCF Fair Value

$50.01

Discounted cash flow valuation reference.

Ben Graham Formula Value

$25.02

Classic Ben Graham valuation formula reference.

DDM Fair Value

$68.90

Dividend discount model valuation reference.

EPV Fair Value

$29.29

Earnings power value estimate.

Comps Fair Value

$42.56

Comparable-company valuation reference.

Analyst Price Target

Not available

Data is currently unavailable.

How to read these valuation models

Use the 7 available valuation references for Orion Oyj ADR (OTC-ORIN.Y) as analytical inputs, not a standalone conclusion. Valuation methods can differ because they rely on different assumptions, time horizons and financial inputs; compare the estimates with the current price and the company’s financial quality.

Profitability • Growth

Profitability & Growth for Orion Oyj ADR (OTC-ORIN.Y)

Review the profitability and growth indicators currently supported by the latest data.

Revenue

2.35 B

Current operating scale indicator.

Revenue Forecast

2.408 B

Forward revenue estimate.

EBITDA

906.7 M

Current operating profitability reference.

EBITDA Forecast

893.5 M

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review Orion Oyj ADR (OTC-ORIN.Y) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Orion Oyj ADR (OTC-ORIN.Y)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Great

Positive financial-health read.

Piotroski Score

8

Relatively strong quality score.

Beneish M-Score

-1.90

Intermediate zone that deserves monitoring.

Altman Z-Score

13.6

Relatively strong balance-sheet zone.

FCF / Net Income

67.0%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Orion Oyj ADR (OTC-ORIN.Y). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Orion Oyj ADR (OTC-ORIN.Y)

Track the upcoming dates and dividend metrics currently supported by the latest data.

Next Earnings Date

February 17, 2027

Days to Earnings

148

Dividend Yield

1.1%

Current income yield reference.

Payout Ratio

41.3%

Dividend payout reference.

How to read events and dividends

This section helps investors track time-sensitive items for Orion Oyj ADR (OTC-ORIN.Y), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Technical Outlook

Technical Signals by Time Frame

Review the technical signals currently available for this stock across supported time frames.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Buy

The 15-minute technical read for Orion Oyj ADR (OTC-ORIN.Y) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Buy

The 1-hour technical read for Orion Oyj ADR (OTC-ORIN.Y) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Buy

The daily technical read for Orion Oyj ADR (OTC-ORIN.Y) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Buy

The weekly technical read for Orion Oyj ADR (OTC-ORIN.Y) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Buy

The monthly technical read for Orion Oyj ADR (OTC-ORIN.Y) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

FAQ • Fast Investor Answers

Orion Oyj ADR (OTC-ORIN.Y) Stock FAQ

Data-supported answers about Orion Oyj ADR (OTC-ORIN.Y), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
$48.17
Estimated upside 2.1%
Valuation Rating
Undervalued
Estimated upside of 2.1%
Financial Health
Great
Current financial-health read

The current fair value estimate for Orion Oyj ADR (OTC-ORIN.Y) is $48.17. This implies an estimated upside of 2.1% versus the current market price.

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 2.1% versus the current market price.

The current financial health read for Orion Oyj ADR (OTC-ORIN.Y) is Great. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Orion Oyj ADR (OTC-ORIN.Y) is February 17, 2027.

Based on the current data, dividend yield is 1.1%.

The current P/E ratio listed for Orion Oyj ADR (OTC-ORIN.Y) is 19.9x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for Orion Oyj ADR is 13.546 B.

The current enterprise value listed for Orion Oyj ADR is 13.325 B. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Orion Oyj ADR is OTC-ORIN.Y, and the stock is listed on OTC Markets.

Orion Oyj ADR (OTC-ORIN.Y) is listed on OTC Markets.

The current debt-to-total-capital ratio listed for Orion Oyj ADR is 1.1%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Orion Oyj ADR is 87.4%. Free float helps investors understand how much of the share base is available for public trading.

Similar Pharmaceuticals Stocks View more on OTC Markets

Comparable companies from the same industry, limited to one security per issuer.

LLY NYSE Eli Lilly and Company Fair Value Fair Market Cap 1,043 B
JNJ NYSE Johnson & Johnson Fair Value Fair Market Cap 648.7 B
MRK NYSE Merck & Company Inc Fair Value Fair Market Cap 372.3 B
NVS NYSE Novartis AG ADR Fair Value Fair Market Cap 269.8 B
NVO NYSE Novo Nordisk A/S Fair Value Bargain Market Cap 175.3 B
PFE NYSE Pfizer Inc Fair Value Fair Market Cap 159.2 B
BMY NYSE Bristol-Myers Squibb Company Fair Value Fair Market Cap 127.2 B
SNY NASDAQ Sanofi ADR Fair Value Undervalued Market Cap 102 B
GSK NYSE GSK plc DRC Fair Value Undervalued Market Cap 101.9 B
TAK NYSE Takeda Pharmaceutical Co Ltd ADR Fair Value Fair Market Cap 60.536 B
TEVA NYSE Teva Pharma Industries Ltd ADR Fair Value Fair Market Cap 46.053 B
HLN NYSE HALEON PLC ADR Fair Value Fair Market Cap 40.268 B
RPRX NASDAQ Royalty Pharma Plc Fair Value Fair Market Cap 33.639 B
ZTS NYSE Zoetis Inc Fair Value Bargain Market Cap 30.107 B
VTRS NASDAQ Viatris Inc Fair Value Undervalued Market Cap 19.733 B
JAZZ NASDAQ Jazz Pharmaceuticals PLC Fair Value Fair Market Cap 15.616 B
CORT NASDAQ Corcept Therapeutics Incorporated Fair Value Overvalued Market Cap 12.702 B
ELAN NYSE Elanco Animal Health Fair Value Fair Market Cap 11.456 B
AXSM NASDAQ Axsome Therapeutics Inc Fair Value Fair Market Cap 10.639 B
RDY NYSE Dr. Reddy’s Laboratories Ltd ADR Fair Value Fair Market Cap 10.564 B